Animal Reservoirs and Hosts for Emerging Alphacoronaviruses and Betacoronaviruses

The ongoing global pandemic caused by coronavirus disease has once again demonstrated the role of the family Coronaviridae in causing human disease outbreaks. Because severe acute respiratory syndrome coronavirus 2 was first detected in December 2019, information on its tropism, host range, and clinical manifestations in animals is limited. Given the limited information, data from other coronaviruses might be useful for informing scientific inquiry, risk assessment, and decision-making. We reviewed endemic and emerging infections of alphacoronaviruses and betacoronaviruses in wildlife, livestock, and companion animals and provide information on the receptor use, known hosts, and clinical signs associated with each host for 15 coronaviruses detected in humans and animals. This information can be used to guide implementation of a One Health approach that involves human health, animal health, environmental, and other relevant partners in developing strategies for preparedness, response, and control to current and future coronavirus disease threats.     

Symptom Diary–Based Analysis of Disease Course among Patients with Mild Coronavirus Disease,Germany, 2020

Limited information is available on the clinical course of outpatients with mild coronavirus disease (COVID-19). This information is critically important to inform public health prevention strategies and to provide anticipatory guidance to patients, primary care providers, and employers. We retrospectively assessed the daily prevalence of symptoms in 313 COVID-19 outpatients for the first 20 days of illness. Generalized estimating equations were used to assess the probability of symptom occurrence over time. Fatigue (91%), cough (85%), and headache (78%) were the most common symptoms and occurred a median of 1 day from symptom onset. Neurologic symptoms, such as loss of taste (66%) and anosmia (62%), and dyspnea (51%) occurred considerably later (median 3–4 days after symptom onset). Symptoms of COVID-19 are similar to those of other respiratory pathogens, so symptomatic patients should be tested more frequently for severe acute respiratory syndrome coronavirus 2 during influenza season to prevent further spread of COVID-19.     

Active Case Finding of Current Bornavirus Infections in Human Encephalitis Cases of Unknown Etiology,Germany, 2018–2020

Human bornavirus encephalitis is a severe and often fatal infection caused by variegated squirrel bornavirus 1 (VSBV-1) and Borna disease virus 1 (BoDV-1). We conducted a prospective study of bornavirus etiology of encephalitis cases in Germany during 2018–2020 by using a serologic testing scheme applied along proposed graded case definitions for VSBV-1, BoDV-1, and unspecified bornavirus encephalitis. Of 103 encephalitis cases of unknown etiology, 4 bornavirus infections were detected serologically. One chronic case was caused by VSBV-1 after occupational-related contact of a person with exotic squirrels, and 3 acute cases were caused by BoDV-1 in virus-endemic areas. All 4 case-patients died. Bornavirus etiology could be confirmed by molecular methods. Serologic testing for these cases was virus specific, discriminatory, and a practical diagnostic option for living patients if no brain tissue samples are available. This testing should be guided by clinical and epidemiologic suspicions, such as residence in virus-endemic areas and animal exposure.     

Surveillance of COVID-19–Associated Multisystem Inflammatory Syndrome in Children,South Korea

A concerning development during the coronavirus disease pandemic has been multisystem inflammatory syndrome in children. Reports of this condition in East Asia have been limited. In South Korea, 3 cases were reported to the national surveillance system for multisystem inflammatory syndrome in children. All case-patients were hospitalized and survived with no major disease sequelae.     

Tula Virus as Causative Agent of Hantavirus Disease in Immunocompetent Person,Germany

We report molecular evidence of Tula virus infection in an immunocompetent patient from Germany who had typical signs of hantavirus disease. Accumulating evidence indicates that Tula virus infection, although often considered nonpathogenic, represents a threat to human health.     

Novel SARS-CoV-2 Variant in Travelers from Brazil to Japan

Multiple severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with higher transmission potential have been emerging globally, including SARS-CoV-2 variants from the United Kingdom and South Africa. We report 4 travelers from Brazil to Japan in January 2021 infected with a novel SARS-CoV-2 variant with an additional set of mutations.     

泌尿道感染常见菌群分布及耐药谱分析

目了：了解泌尿道感染常见菌群分布及其对抗生素的耐药性。方法：分析474例从临床尿标本分离出的菌株并测定其对常见抗生素的耐药性。结果：泌尿道感染常见致病菌是大肠杆菌,绿脓杆菌和肺炎克雷伯氏杆菌,大肠杆菌地阿莫西林／棒酸,哌拉西林／他唑巴坦的耐药率为24％－38％,对第3代头孢菌素的耐药率为12－22％,绿脓杆菌和阴沟肠杆菌耐药率较高,且多重耐药。结论：定期系统的细菌耐药性监测对临床用药具有重要意义。     

不同剂量头孢曲松钠预防泌尿系术后感染的疗效-成本比较

目的 :探讨不同剂量头孢曲松钠预防泌尿术后感染的疗效 -成本分析。方法 :应用两组不同剂量头孢曲松钠防止泌尿系手术后感染的疗效进行比较 ,并运用药物经济学原理进行成本分析。结果 :单剂量与双剂量组头孢曲松钠防止泌尿系手术后感染有效率分别为 80 9%与 84 8% ,统计学差异不显著 (P >0 0 5 ) ;费用效果比值分别为1 95与 3 73,统计学差异显著 (P <0 0 5 )。结论 :使用单剂量头孢曲松钠能有效地防御泌尿系手术后感染 ,是一种预防术后感染有效、安全、经济的方法     

肾移植术后巨细胞病毒感染与急性排斥反应

目的 :探讨肾移植术后活动性巨细胞病毒 (CMV)感染的发生率、原因以及对急性排斥反应的影响。方法 :检测 182例肾移植受者及其供者术前血清抗CMV抗体 ,受者术后定期PCR法检测体内CMVDNA ,对CMVDNA阳性的部分患者给予抗CMV治疗 ,并比较各组排斥反应的发生率。结果 :无论是供者还是受者 ,术前如血清抗CMV抗体阳性 ,受者术后发生活动性CMV感染者明显增多 ,且急性排斥反应的发生率亦明显增加 ;接受抗病毒治疗急性排斥反应明显减少。结论 :CMV感染是肾移植术后急性排斥反应的原因之一 ,预防和治疗CMV感染对肾移植术后急性排斥反应的防治具有重要意义。     

关节假体周围感染患者血清学指标未达诊断阈值的影响因素分析

目的探讨关节假体周围感染(periprosthetic joint infection,PJI)患者血清C反应蛋白(C-reactive protein,CRP)和红细胞沉降率(erythrocyte sedimentation rate,ESR)不符合2011版美国肌肉骨骼感染协会(Musculoskeletal Infection Society,MSIS)诊断标准的影响因素。方法2011年12月至2019年12月因PJI住院治疗的患者328例,男152例、女176例,年龄(62.10±13.74)岁(范围24~87岁);膝关节172例(52.4%),髋关节151例(46.0%),肘关节4例(1.2%),肩关节1例(0.3%)。所有患者均于术前或应用抗生素前行CRP和ESR检测,PJI的诊断采用2011版MSIS诊断标准:CRP≥10 mg/L且ESR≥30 mm/1 h。将患者根据Tsukayama分型、病原体类型及免疫状态等进行分组,比较不同组别患者CRP和ESR不符合MSIS标准(即未达诊断阈值)的发生率。结果119例(36.3%,119/328)CRP或ESR实测值不符合MSIS诊断标准。Tsukayama分型组间不符合率的差异无统计学意义(χ^2=7.224,P=0.065);培养结果阴性组不符合率为46.4%,高于培养阳性组的27.4%(χ^2=12.276,P<0.001);免疫A级组不符合率为42.9%,高于免疫B级组的30.6%和C级组的23.8%(χ^2=6.586,P=0.037)。Logistic回归分析结果提示,培养结果阳性患者发生不符合标准的风险是培养阴性患者的0.420倍(P=0.001);免疫B级患者出现不符合标准现象的风险是免疫A级患者的0.578倍(P=0.040)。结论免疫状态好及培养结果阴性的PJI患者更容易出现血清学指标未达诊断阈值的现象,诊断时应特别注意综合其他指标,以防漏诊。